Facebook
Twitter
Telegram
Report an ErrorViridian Therapeutics Cash Flow 2011-2024 | VRDN
Annual Cash Flow Viridian Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-184 M | -93.8 M | -54.6 M | -29.8 M | -36.1 M | -26.8 M | -28.2 M | -14.8 M | -6.9 M | -2.21 M | -1.17 M | - | - |
Depreciation & Amortization |
522 K | 255 K | 120 K | 239 K | 288 K | 281 K | 308 K | 341 K | 184 K | 144 K | 148 K | - | - |
Accounts Payables |
2.24 M | 14.2 M | 2.33 M | 670 K | 1.1 M | 571 K | 906 K | 159 K | 242 K | 255 K | - | - | - |
Accounts Receivables |
- | - | - | - | 108 K | 24 K | 1.46 M | 524 K | 394 K | 1.09 M | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | 187 K | 179 K | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Viridian Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-45.2 M | - | - | - | -62 M | - | -59.8 M | -39.1 M | -21 M | - | -38 M | -26.2 M | -11.5 M | - | -20.3 M | -15.2 M | -8.46 M | - | -28.2 M | -19 M | -11.8 M | - | -18.7 M | -11.9 M | -7.36 M | - | -20.9 M | -15.3 M | -8.18 M | - | -11.5 M | -8.63 M | -4.17 M | - | -5.6 M | -3.3 M | -1.11 M | - | -1.22 M | -385 K | 85 K | - | -810 K | -514 K | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
145 K | - | - | - | 105 K | - | 159 K | 97 K | 40 K | - | 88 K | 58 K | 33 K | - | 57 K | 64 K | 68 K | - | 100 K | 100 K | 73 K | - | 100 K | 100 K | 69 K | - | 100 K | 100 K | 73 K | - | 100 K | 100 K | 81 K | - | 137 K | 90 K | 45 K | - | 34 K | 36 K | 36 K | - | 37 K | 38 K | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.68 M | 2.24 M | 3.74 M | 4.13 M | 7.87 M | 14.2 M | 12.2 M | 4.06 M | 2.54 M | 2.33 M | 3.73 M | 2.39 M | 3.38 M | 670 K | 670 K | 670 K | 670 K | 1.1 M | 1.1 M | 1.1 M | 1.1 M | 571 K | 571 K | 571 K | 571 K | 906 K | 906 K | 906 K | 906 K | 1.01 M | 1.01 M | 1.01 M | 1.01 M | 242 K | 242 K | 242 K | 242 K | 255 K | 255 K | 255 K | 255 K | 100 K | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 57 K | 248 K | 4 K | 108 K | 979 K | 108 K | 108 K | 24 K | 24 K | 24 K | 24 K | 1.46 M | 1.46 M | 1.46 M | 1.46 M | 20 K | 20 K | 20 K | 20 K | 394 K | 394 K | 394 K | 394 K | 1.09 M | 1.09 M | 1.09 M | 1.09 M | 994 K | 994 K | 994 K | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 64 K | 62 K | 213 K | 269 K | 187 K | 187 K | 187 K | 187 K | 179 K | 179 K | 179 K | 179 K | 357 K | 357 K | 357 K | - | - | - | - | - | - | - | - | - |
All numbers in USD currency